NINJ1 抗体
(Ninjurin 1 (NINJ1))
The ninjurin protein is upregulated after nerve injury both in dorsal root ganglion neurons and in Schwann cells (Araki and Milbrandt, 1996 [PubMed 8780658]). It demonstrates properties of a homophilic adhesion molecule and promotes neurite outgrowth from primary cultured dorsal root ganglion neurons.[supplied by OMIM, Aug 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| NINJ1 抗体 (AA 1-80) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-80) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-152) | 人 | 小鼠 Polyclonal |
|
|
|
| NINJ1 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-80) (AbBy Fluor® 555) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-80) (AbBy Fluor® 350) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-80) (AbBy Fluor® 594) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-80) (Cy5.5) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-80) (Cy7) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-80) (AbBy Fluor® 750) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-80) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-80) (Cy5) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-80) (AbBy Fluor® 647) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-80) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-80) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-80) (AbBy Fluor® 680) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-80) (AbBy Fluor® 488) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (AA 1-80) (Cy3) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (PE) | 人 | 兔 Polyclonal |
|
|
|
| NINJ1 抗体 (PE-Cy5) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
2 references - 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-152
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 555
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 350
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 594
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5.5
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy7
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 750
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 647
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 680
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 488
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE-Cy5
- 抗体亚型
- IgG
Latest Publications for our NINJ1 抗体
: "Pericyte-Specific Ninjurin1 Deletion Attenuates Vessel Maturation and Blood Flow Recovery in Hind Limb Ischemia." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 38, Issue 10, pp. 2358-2370, (2019) (PubMed).
: "Ninjurin1 Is a Novel Factor to Regulate Angiogenesis Through the Function of Pericytes." in: Circulation journal : official journal of the Japanese Circulation Society, (2015) (PubMed).
: "Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia." in: Blood, Vol. 97, Issue 7, pp. 2115-20, (2001) (PubMed).
: "Mechanism of homophilic binding mediated by ninjurin, a novel widely expressed adhesion molecule." in: The Journal of biological chemistry, Vol. 272, Issue 34, pp. 21373-80, (1997) (PubMed).
: "Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth." in: Neuron, Vol. 17, Issue 2, pp. 353-61, (1996) (PubMed).
: "Ninjurin1 Is a Novel Factor to Regulate Angiogenesis Through the Function of Pericytes." in: Circulation journal : official journal of the Japanese Circulation Society, (2015) (PubMed).
: "Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia." in: Blood, Vol. 97, Issue 7, pp. 2115-20, (2001) (PubMed).
: "Mechanism of homophilic binding mediated by ninjurin, a novel widely expressed adhesion molecule." in: The Journal of biological chemistry, Vol. 272, Issue 34, pp. 21373-80, (1997) (PubMed).
: "Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth." in: Neuron, Vol. 17, Issue 2, pp. 353-61, (1996) (PubMed).
Aliases for NINJ1 抗体
ninjurin 1 (NINJ1) 抗体ninjurin 1 (ninj1) 抗体
ninjurin 1 L homeolog (ninj1.L) 抗体
ninjurin 1 (Ninj1) 抗体
AU024536 抗体
MGC79511 抗体
nin1 抗体
NIN1 抗体
ninjurin 抗体
NINJURIN 抗体
您还需要查找其他产品吗？
You are here:
